Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adherens junction 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Adherens junction
| Linsitinib | 232 [1] 232 💬1. Adherens junction
|
||||||||||||||||||
| 2 | Adherens junction 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Adherens junction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬2. Adherens junction
|
||||||||||||||||||
| 3 | Adherens junction 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Adherens junction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬2. Adherens junction
|
||||||||||||||||||
| 4 | AMPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬AMPK signaling pathway
| Linsitinib | 232 [1] 232 💬4. AMPK signaling pathway
|
||||||||||||||||||
| 5 | AMPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬AMPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬5. AMPK signaling pathway
|
||||||||||||||||||
| 6 | AMPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬AMPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬5. AMPK signaling pathway
|
||||||||||||||||||
| 7 | Autophagy - animal 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Autophagy - animal
| Linsitinib | 232 [1] 232 💬7. Autophagy - animal
|
||||||||||||||||||
| 8 | Autophagy - animal 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Autophagy - animal
| Mecasermin | 096 [4] 96, 168, 265, 299 💬8. Autophagy - animal
|
||||||||||||||||||
| 9 | Autophagy - animal 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Autophagy - animal
| Mecasermin | 096 [4] 96, 168, 265, 299 💬8. Autophagy - animal
|
||||||||||||||||||
| 10 | Breast cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Breast cancer
| Linsitinib | 232 [1] 232 💬10. Breast cancer
|
||||||||||||||||||
| 11 | Breast cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Breast cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬11. Breast cancer
|
||||||||||||||||||
| 12 | Breast cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Breast cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬11. Breast cancer
|
||||||||||||||||||
| 13 | Endocytosis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Endocytosis
| Linsitinib | 232 [1] 232 💬13. Endocytosis
|
||||||||||||||||||
| 14 | Endocytosis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Endocytosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬14. Endocytosis
|
||||||||||||||||||
| 15 | Endocytosis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Endocytosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬14. Endocytosis
|
||||||||||||||||||
| 16 | Focal adhesion 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Focal adhesion
| Linsitinib | 232 [1] 232 💬16. Focal adhesion
|
||||||||||||||||||
| 17 | Focal adhesion 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Focal adhesion
| Mecasermin | 096 [4] 96, 168, 265, 299 💬17. Focal adhesion
|
||||||||||||||||||
| 18 | Focal adhesion 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Focal adhesion
| Mecasermin | 096 [4] 96, 168, 265, 299 💬17. Focal adhesion
|
||||||||||||||||||
| 19 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬FoxO signaling pathway
| Linsitinib | 232 [1] 232 💬19. FoxO signaling pathway
|
||||||||||||||||||
| 20 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬FoxO signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬20. FoxO signaling pathway
|
||||||||||||||||||
| 21 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬FoxO signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬20. FoxO signaling pathway
|
||||||||||||||||||
| 22 | Glioma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Glioma
| Linsitinib | 232 [1] 232 💬22. Glioma
|
||||||||||||||||||
| 23 | Glioma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Glioma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬23. Glioma
|
||||||||||||||||||
| 24 | Glioma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Glioma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬23. Glioma
|
||||||||||||||||||
| 25 | Hepatocellular carcinoma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Hepatocellular carcinoma
| Linsitinib | 232 [1] 232 💬25. Hepatocellular carcinoma
|
||||||||||||||||||
| 26 | Hepatocellular carcinoma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Hepatocellular carcinoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬26. Hepatocellular carcinoma
|
||||||||||||||||||
| 27 | Hepatocellular carcinoma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Hepatocellular carcinoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬26. Hepatocellular carcinoma
|
||||||||||||||||||
| 28 | HIF-1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬HIF-1 signaling pathway
| Linsitinib | 232 [1] 232 💬28. HIF-1 signaling pathway
|
||||||||||||||||||
| 29 | HIF-1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬HIF-1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬29. HIF-1 signaling pathway
|
||||||||||||||||||
| 30 | HIF-1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬HIF-1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬29. HIF-1 signaling pathway
|
||||||||||||||||||
| 31 | Hormone signaling 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Hormone signaling
| Linsitinib | 232 [1] 232 💬31. Hormone signaling
|
||||||||||||||||||
| 32 | Hormone signaling 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Hormone signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬32. Hormone signaling
|
||||||||||||||||||
| 33 | Hormone signaling 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Hormone signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬32. Hormone signaling
|
||||||||||||||||||
| 34 | Long-term depression 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Long-term depression
| Linsitinib | 232 [1] 232 💬34. Long-term depression
|
||||||||||||||||||
| 35 | Long-term depression 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Long-term depression
| Mecasermin | 096 [4] 96, 168, 265, 299 💬35. Long-term depression
|
||||||||||||||||||
| 36 | Long-term depression 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Long-term depression
| Mecasermin | 096 [4] 96, 168, 265, 299 💬35. Long-term depression
|
||||||||||||||||||
| 37 | Longevity regulating pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Longevity regulating pathway
| Linsitinib | 232 [1] 232 💬37. Longevity regulating pathway
|
||||||||||||||||||
| 38 | Longevity regulating pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Longevity regulating pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬38. Longevity regulating pathway
|
||||||||||||||||||
| 39 | Longevity regulating pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Longevity regulating pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬38. Longevity regulating pathway
|
||||||||||||||||||
| 40 | Longevity regulating pathway - multiple species 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Longevity regulating pathway - multiple species
| Linsitinib | 232 [1] 232 💬40. Longevity regulating pathway - multiple species
|
||||||||||||||||||
| 41 | Longevity regulating pathway - multiple species 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Longevity regulating pathway - multiple species
| Mecasermin | 096 [4] 96, 168, 265, 299 💬41. Longevity regulating pathway - multiple species
|
||||||||||||||||||
| 42 | Longevity regulating pathway - multiple species 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Longevity regulating pathway - multiple species
| Mecasermin | 096 [4] 96, 168, 265, 299 💬41. Longevity regulating pathway - multiple species
|
||||||||||||||||||
| 43 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬MAPK signaling pathway
| Linsitinib | 232 [1] 232 💬43. MAPK signaling pathway
|
||||||||||||||||||
| 44 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬MAPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬44. MAPK signaling pathway
|
||||||||||||||||||
| 45 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬MAPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬44. MAPK signaling pathway
|
||||||||||||||||||
| 46 | Melanoma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Melanoma
| Linsitinib | 232 [1] 232 💬46. Melanoma
|
||||||||||||||||||
| 47 | Melanoma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Melanoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬47. Melanoma
|
||||||||||||||||||
| 48 | Melanoma 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Melanoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬47. Melanoma
|
||||||||||||||||||
| 49 | mTOR signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬mTOR signaling pathway
| Linsitinib | 232 [1] 232 💬49. mTOR signaling pathway
|
||||||||||||||||||
| 50 | mTOR signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬mTOR signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬50. mTOR signaling pathway
|
||||||||||||||||||
| 51 | mTOR signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬mTOR signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬50. mTOR signaling pathway
|
||||||||||||||||||
| 52 | Oocyte meiosis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Oocyte meiosis
| Linsitinib | 232 [1] 232 💬52. Oocyte meiosis
|
||||||||||||||||||
| 53 | Oocyte meiosis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Oocyte meiosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬53. Oocyte meiosis
|
||||||||||||||||||
| 54 | Oocyte meiosis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Oocyte meiosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬53. Oocyte meiosis
|
||||||||||||||||||
| 55 | Ovarian steroidogenesis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Ovarian steroidogenesis
| Linsitinib | 232 [1] 232 💬55. Ovarian steroidogenesis
|
||||||||||||||||||
| 56 | Ovarian steroidogenesis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Ovarian steroidogenesis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬56. Ovarian steroidogenesis
|
||||||||||||||||||
| 57 | Ovarian steroidogenesis 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Ovarian steroidogenesis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬56. Ovarian steroidogenesis
|
||||||||||||||||||
| 58 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Pathways in cancer
| Linsitinib | 232 [1] 232 💬58. Pathways in cancer
|
||||||||||||||||||
| 59 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Pathways in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬59. Pathways in cancer
|
||||||||||||||||||
| 60 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Pathways in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬59. Pathways in cancer
|
||||||||||||||||||
| 61 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬PI3K-Akt signaling pathway
| Linsitinib | 232 [1] 232 💬61. PI3K-Akt signaling pathway
|
||||||||||||||||||
| 62 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬PI3K-Akt signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬62. PI3K-Akt signaling pathway
|
||||||||||||||||||
| 63 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬PI3K-Akt signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬62. PI3K-Akt signaling pathway
|
||||||||||||||||||
| 64 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Progesterone-mediated oocyte maturation
| Linsitinib | 232 [1] 232 💬64. Progesterone-mediated oocyte maturation
|
||||||||||||||||||
| 65 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Progesterone-mediated oocyte maturation
| Mecasermin | 096 [4] 96, 168, 265, 299 💬65. Progesterone-mediated oocyte maturation
|
||||||||||||||||||
| 66 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Progesterone-mediated oocyte maturation
| Mecasermin | 096 [4] 96, 168, 265, 299 💬65. Progesterone-mediated oocyte maturation
|
||||||||||||||||||
| 67 | Prostate cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Prostate cancer
| Linsitinib | 232 [1] 232 💬67. Prostate cancer
|
||||||||||||||||||
| 68 | Prostate cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Prostate cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬68. Prostate cancer
|
||||||||||||||||||
| 69 | Prostate cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Prostate cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬68. Prostate cancer
|
||||||||||||||||||
| 70 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Proteoglycans in cancer
| Linsitinib | 232 [1] 232 💬70. Proteoglycans in cancer
|
||||||||||||||||||
| 71 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Proteoglycans in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬71. Proteoglycans in cancer
|
||||||||||||||||||
| 72 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Proteoglycans in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬71. Proteoglycans in cancer
|
||||||||||||||||||
| 73 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Rap1 signaling pathway
| Linsitinib | 232 [1] 232 💬73. Rap1 signaling pathway
|
||||||||||||||||||
| 74 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Rap1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬74. Rap1 signaling pathway
|
||||||||||||||||||
| 75 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Rap1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬74. Rap1 signaling pathway
|
||||||||||||||||||
| 76 | Ras signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Ras signaling pathway
| Linsitinib | 232 [1] 232 💬76. Ras signaling pathway
|
||||||||||||||||||
| 77 | Ras signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Ras signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬77. Ras signaling pathway
|
||||||||||||||||||
| 78 | Ras signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Ras signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬77. Ras signaling pathway
|
||||||||||||||||||
| 79 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Signaling pathways regulating pluripotency of stem cells
| Linsitinib | 232 [1] 232 💬79. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||
| 80 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Signaling pathways regulating pluripotency of stem cells
| Mecasermin | 096 [4] 96, 168, 265, 299 💬80. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||
| 81 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Signaling pathways regulating pluripotency of stem cells
| Mecasermin | 096 [4] 96, 168, 265, 299 💬80. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||
| 82 | Transcriptional misregulation in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Linsitinib Linsitinib 💬Transcriptional misregulation in cancer
| Linsitinib | 232 [1] 232 💬82. Transcriptional misregulation in cancer
|
||||||||||||||||||
| 83 | Transcriptional misregulation in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Transcriptional misregulation in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬83. Transcriptional misregulation in cancer
|
||||||||||||||||||
| 84 | Transcriptional misregulation in cancer 💬 1 gene, 2 drugs (DrugBank) and 5 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Transcriptional misregulation in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬83. Transcriptional misregulation in cancer
|
Adherens junction
1 gene, 2 drugs (DrugBank) and 5 diseases
AMPK signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Autophagy - animal
1 gene, 2 drugs (DrugBank) and 5 diseases
Breast cancer
1 gene, 2 drugs (DrugBank) and 5 diseases
Endocytosis
1 gene, 2 drugs (DrugBank) and 5 diseases
Focal adhesion
1 gene, 2 drugs (DrugBank) and 5 diseases
FoxO signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Glioma
1 gene, 2 drugs (DrugBank) and 5 diseases
Hepatocellular carcinoma
1 gene, 2 drugs (DrugBank) and 5 diseases
HIF-1 signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Hormone signaling
1 gene, 2 drugs (DrugBank) and 5 diseases
Long-term depression
1 gene, 2 drugs (DrugBank) and 5 diseases
Longevity regulating pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Longevity regulating pathway - multiple species
1 gene, 2 drugs (DrugBank) and 5 diseases
MAPK signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Melanoma
1 gene, 2 drugs (DrugBank) and 5 diseases
mTOR signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Oocyte meiosis
1 gene, 2 drugs (DrugBank) and 5 diseases
Ovarian steroidogenesis
1 gene, 2 drugs (DrugBank) and 5 diseases
Pathways in cancer
1 gene, 2 drugs (DrugBank) and 5 diseases
PI3K-Akt signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Progesterone-mediated oocyte maturation
1 gene, 2 drugs (DrugBank) and 5 diseases
Prostate cancer
1 gene, 2 drugs (DrugBank) and 5 diseases
Proteoglycans in cancer
1 gene, 2 drugs (DrugBank) and 5 diseases
Rap1 signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Ras signaling pathway
1 gene, 2 drugs (DrugBank) and 5 diseases
Signaling pathways regulating pluripotency of stem cells
1 gene, 2 drugs (DrugBank) and 5 diseases
Transcriptional misregulation in cancer
1 gene, 2 drugs (DrugBank) and 5 diseases
